A Phase Ii Trial Of Bortezomib Plus Lenalidomide For Relapsed/Refractory Mantle Cell Lymphoma (Mcl) (Calgb 50501).Vicki A Morrison,Sinho Jung,Johanna L Johnson,John P Leonard,Bruce D Cheson, CancerJOURNAL OF CLINICAL ONCOLOGY（2011）引用 2|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
